Boston researchers may have found biomarker for long COVID - The Boston Globe
“Strikingly, we detect SARS-CoV-2 spike antigen in a majority of [long COVID] patients up to 12 months post-diagnosis, suggesting the presence of an active persistent SARSCoV-2 viral reservoir,” the study said.